New impact factors for Society's journals announced!

Another year in a row, we are proud to announce that Society’s newly announced impact factors are a reason for celebration.Journal of Endocrinology,ranked in the top quartile of journals in the endocrinology and metabolism category, has received a 2017 impact factor of 4.012 and a five-year impact factor of 4.276, a longer term measure of the relevance of paper’s published in the journal.TheJournal of Molecular Endocrinology’s 2017 impact factor remains steady at 3.297 with the five-year measure increasing to 3.636. The journal continues to be the leading journal in molecular endocrinology, and we would like to thank the world-class editors, authors and reviewers to whom this success can be attributed.Endocrine-Related Cancer has received an increased 2017 impact factor of 5.331, its highest since 2003. The journal remains in the top quartile of both its categories, ranking 21/143 in the endocrinology and metabolism category and 43/222 in the oncology category, strengthening its position as the leading journal linking oncology and endocrinology.Endocrine Connections’ second impact factor has jumped up to 3.041, a continuing reflection of the high quality research and reviews being published in the journal. The journal is now 73/143 journals in the endocrinology and metabolism ranking.Clinical Endocrinology has received a strong impact factor of 3.077.Members benefits include free online access to the Society's subscription journals throug...
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

A new study inCancer Management and Research found a correlation between the age of patients with papillary thyroid cancer and lymph node positivity.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
Measures of frailty and comorbidity failed to offer predictive information regarding complications in patients with bladder cancer undergoing radical cystectomy.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?, Published online: 17 October 2018; doi:10.1038/s41416-018-0245-0Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults, Published online: 17 October 2018; doi:10.1038/s41416-018-0214-7Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0296-2Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0291-7CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Breast osteoblast-like cells: a new biomarker for the management of breast cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0255-yBreast osteoblast-like cells: a new biomarker for the management of breast cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma, Published online: 17 October 2018; doi:10.1038/s41416-018-0175-xCombination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers, Published online: 17 October 2018; doi:10.1038/s41416-018-0276-6A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”, Published online: 17 October 2018; doi:10.1038/s41416-018-0177-8Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
More News: Cancer | Cancer & Oncology | Endocrinology